Literature DB >> 11439208

Time-dose-response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas.

V P Muriel1, M R Tejada, J de Dios Luna del Castillo.   

Abstract

BACKGROUND AND
PURPOSE: To define the influence of the dose and time on the response to treatment in postoperatively irradiated head and neck cancer patients and to establish a good prediction of failure. METHODS AND MATERIALS: From January 1985 to December 1995, 214 patients with histologically proven head and neck squamous cell carcinomas were irradiated after radical surgery or single tumour resection according to surgical and histopathological findings. The total doses given ranged between 50 and 75 Gy to the primary bed tumour and between 42 and 56 Gy to the neck with fraction sizes of 1.7-2 Gy/day. The median length of the time interval between surgery and radiotherapy, time of irradiation and total treatment time were 81, 59 and 139 days, respectively. The end-point analyzed was the local-regional tumour control rate at the primary tumour bed and neck for 5 years from the beginning of radiotherapy. Univariate and multivariate analyses were used to determine predictors of failure from among the following studied variables: (i), clinical stage (T/N) of the patients; (ii), tumour grade; (iii), neck surgery; (iv), tumour margins; (v), histological tumour nodal extension; (vi), chemotherapy; (vii), normalized total dose; (viii), time interval between surgery and radiotherapy; (ix), time of irradiation; and (x), total treatment time.
RESULTS: The actuarial 5-year tumour control rate for the entire group was 72%, and 92% of the patients who achieved local control are currently alive without disease. Tumour control was inversely related to T stage (83% for T2 vs. 57% for T4) and the probability of local control within each stage was dependent on the N status (> or =71% for T3-T4/N0 vs. 31-44% for T3-T4/N1-N3). Histological N status and tumour margins, but not tumour grade, impacted significantly on tumour control. When local control was analyzed as a function of the dose to the primary, a non-significant negative dose-response relationship was found. The total treatment time was a significant prognostic factor, and the time interval between surgery and irradiation proved to be an independent predictor of failure.
CONCLUSIONS: Despite the absence of a statistically significant dose-response relationship, the present results suggest that postoperative irradiation treatment given to patients with head and neck squamous cell carcinomas should not be unduly prolonged, in order to minimize the amount of tumour cell proliferation. In these patients, nodal involvement, positive margins of the resected specimens and time interval between surgery and irradiation were the most important prognostic factors.

Entities:  

Mesh:

Year:  2001        PMID: 11439208     DOI: 10.1016/s0167-8140(01)00381-4

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

Review 1.  The impact on oncology of the interaction of radiation therapy and radiobiology.

Authors:  Vicente Pedraza Muriel
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

Review 2.  Radiobiological considerations in combining doses from external beam radiotherapy and brachytherapy for cervical cancer.

Authors:  Ana M Tornero-López; Damián Guirado
Journal:  Rep Pract Oncol Radiother       Date:  2018-07-02

3.  Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.

Authors:  Evan M Graboyes; Elizabeth Garrett-Mayer; Mark A Ellis; Anand K Sharma; Amy E Wahlquist; Eric J Lentsch; Brian Nussenbaum; Terry A Day
Journal:  Cancer       Date:  2017-08-25       Impact factor: 6.860

Review 4.  Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature.

Authors:  José A González Ferreira; Javier Jaén Olasolo; Ignacio Azinovic; Branislav Jeremic
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-04

5.  The impact of treatment center on the outcome of patients with laryngeal cancer treated with surgery and radiotherapy.

Authors:  Fadime Can Akman; Nihal Dag; Ozlem Uruk Ataman; Cenk Ecevit; Ahmet Omer Ikiz; Isin Arslan; Sulen Sarioglu; Emel Ada; Munir Kinay
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-05       Impact factor: 2.503

6.  Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer.

Authors:  Jeremy P Harris; Michelle M Chen; Ryan K Orosco; Davud Sirjani; Vasu Divi; Wendy Hara
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-04-01       Impact factor: 6.223

7.  Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer.

Authors:  Chen-Hsi Hsieh; Ying-Shiung Kuo; Li-Jen Liao; Kawang-Yu Hu; Shih-Chiang Lin; Le-Jung Wu; Yu-Chin Lin; Yu-Jen Chen; Li-Ying Wang; Yen-Ping Hsieh; Shoei Long Lin; Chun-Yi Chen; Chien-An Chen; Pei-Wei Shueng
Journal:  BMC Cancer       Date:  2011-01-27       Impact factor: 4.430

8.  Treatment results and prognostic factors of patients undergoing postoperative radiotherapy for laryngeal squamous cell carcinoma.

Authors:  Ting Jin; Wei-Han Hu; Li-Bing Guo; Wen-Kuan Chen; Qiu-Li Li; Hui Lin; Xiu-Yu Cai; Nan Ge; Rui Sun; Si-Yi Bu; Xin Zhang; Meng-Yao Qiu; Wei Zhang; Su Luo; Yi-Xin Zhou
Journal:  Chin J Cancer       Date:  2011-07

9.  Impact of postoperative daily image-guided intensity-modulated radiotherapy on overall and local progression-free survival in patients with oral cavity cancer.

Authors:  Chen-Hsi Hsieh; Pei-Wei Shueng; Li-Ying Wang; Yu-Chuen Huang; Li-Jen Liao; Wu-Chia Lo; Yu-Chin Lin; Le-Jung Wu; Hui-Ju Tien
Journal:  BMC Cancer       Date:  2016-02-23       Impact factor: 4.430

10.  The effect of treatment package time in head and neck cancer patients treated with adjuvant radiotherapy and concurrent systemic therapy.

Authors:  Ahmed I Ghanem; Matthew Schymick; Souheyla Bachiri; Aniruddh Mannari; Jawad Sheqwara; Charlotte Burmeister; Steven Chang; Tamer Ghanem; Farzan Siddiqui
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2019-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.